Selpercatinib: Capsules for oral administration
The drug Selpercatinib is sold under the brand name Retevmo which is used to treat metastatic RET fusion-positive non-small cell lung carcinoma, advanced or metastatic RET-mutant medullary thyroid ca, carcinoma, advanced or metastatic RET fusion-positive thyroid cancer. This medicine is supplied in 40 mg and 80 mg capsules for oral administration. Selpercatinib may be taken with or without food unless coadministered with a proton pump inhibitor (PPI).
One can readily purchase Selpercatinib capsules from licensed generic medicine suppliers. For further details, call 1800-889-1064.